[March 12, 2013]

The Myelin Repair Foundation Receives $2 Million Gift from Anonymous Trust to Accelerate Myelin Repair Therapeutics for Multiple Sclerosis

The Myelin Repair Foundation (MRF) today announced the generous donation of $2 million from an anonymous trust, to support the acceleration of myelin repair therapeutic development for multiple sclerosis (MS). Following a thorough vetting process to maximize the gift's impact to help MS patients, the Myelin Repair Foundation was selected to receive the donation.

The Myelin Repair Foundation was named the recipient of this bequest in the will of the anonymous donor whose niece and nephew have MS. Multiple Sclerosis is a disease associated with a genetic predisposition and can run in families.

This donation will support the Myelin Repair Foundation's unique approach to speed myelin repair research throughout the entire therapeutic development continuum, ensuring promising basic scientific research moves forward to prepare the best compounds for clinical trials. The MRF established its Accelerated Research Collaboration™ (ARC™) model, allowing for seamless coordination between academia, the biopharma industry and other entities throughout the therapeutics development process to advance clinically relevant science forward to patients.

"We are honored to receive this generous gift, following a careful assessment by the donor of our ARC model and our plan to bring a myelin repair drug to MS patients," said Scott Johnson, CEO, President and Founder of the Myelin Repair Foundation. "This donation will help propel our research forward, bringing us closer to our goal-alleviating suffering from MS by delivering the first myelin repair therapeutic to the MS community."

Founded by Scott Johnson, a patient with multiple sclerosis, the Myelin Repair Foundation is uniquely positioned as a non-profit organization to interact with the various entities throughout the drug development process and coordinating efforts to advance research forward into the clinical setting. As a non-profit, the MRF is exclusively dedicated to meeting patient need.

About the Myelin Repair Foundation

The Myelin Repair Foundation (MRF) (http://www.myelinrepair.org) is a Silicon Valley-based, non-profit research organization focused on accelerating the discovery and development of myelin repair therapeutics for multiple sclerosis. Its Accelerated Research Collaboration™ (ARC™) model is designed to optimize the entire therapeutics development process for all diseases.

[ Back To Technology News's Homepage ]